BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 18395771)

  • 1. Lipid profiles in patients with rheumatoid arthritis: mechanisms and the impact of treatment.
    Steiner G; Urowitz MB
    Semin Arthritis Rheum; 2009 Apr; 38(5):372-81. PubMed ID: 18395771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conventional lipid profile and lipoprotein(a) concentrations in treated patients with rheumatoid arthritis.
    García-Gómez C; Nolla JM; Valverde J; Gómez-Gerique JA; Castro MJ; Pintó X
    J Rheumatol; 2009 Jul; 36(7):1365-70. PubMed ID: 19369465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interpreting lipid levels in the context of high-grade inflammatory states with a focus on rheumatoid arthritis: a challenge to conventional cardiovascular risk actions.
    Choy E; Sattar N
    Ann Rheum Dis; 2009 Apr; 68(4):460-9. PubMed ID: 19286905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Relationship between blood lipid spectrum and activity of the disease in patients with rheumatoid arthritis].
    Shirinskiĭ IV; Zheltova OI; Shirinskiĭ VS; Kozlova VA
    Klin Med (Mosk); 2008; 86(12):40-3. PubMed ID: 19227308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High HDL-cholesterol in women with rheumatoid arthritis on low-dose glucocorticoid therapy.
    García-Gómez C; Nolla JM; Valverde J; Narváez J; Corbella E; Pintó X
    Eur J Clin Invest; 2008 Sep; 38(9):686-92. PubMed ID: 18837746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early treatment reduces the cardiovascular risk factors in newly diagnosed rheumatoid arthritis patients.
    Georgiadis AN; Voulgari PV; Argyropoulou MI; Alamanos Y; Elisaf M; Tselepis AD; Drosos AA
    Semin Arthritis Rheum; 2008 Aug; 38(1):13-9. PubMed ID: 18191989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipid profiles among US elderly with untreated rheumatoid arthritis--the Third National Health and Nutrition Examination Survey.
    Choi HK; Seeger JD
    J Rheumatol; 2005 Dec; 32(12):2311-6. PubMed ID: 16331755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Indications for lowering LDL cholesterol in rheumatoid arthritis: an unrecognized problem.
    Soubrier M; Zerkak D; Dougados M
    J Rheumatol; 2006 Sep; 33(9):1766-9. PubMed ID: 16845709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are lipid ratios less susceptible to change with systemic inflammation than individual lipid components in patients with rheumatoid arthritis?
    Toms TE; Panoulas VF; Douglas KM; Nightingale P; Smith JP; Griffiths H; Sattar N; Symmons DP; Kitas GD
    Angiology; 2011 Feb; 62(2):167-75. PubMed ID: 20682616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No significant change in arterial stiffness in RA after 6 months and 1 year of rituximab treatment.
    Mathieu S; Pereira B; Dubost JJ; Lusson JR; Soubrier M
    Rheumatology (Oxford); 2012 Jun; 51(6):1107-11. PubMed ID: 22328565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atherogenic lipid profiles in rheumatoid arthritis.
    White D; Fayez S; Doube A
    N Z Med J; 2006 Aug; 119(1240):U2125. PubMed ID: 16924276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular risk in rheumatoid arthritis: effects of anti-TNF drugs.
    Avouac J; Allanore Y
    Expert Opin Pharmacother; 2008 May; 9(7):1121-8. PubMed ID: 18422470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-inflammatory therapy with tumour necrosis factor alpha inhibitors improves high-density lipoprotein cholesterol antioxidative capacity in rheumatoid arthritis patients.
    Popa C; van Tits LJ; Barrera P; Lemmers HL; van den Hoogen FH; van Riel PL; Radstake TR; Netea MG; Roest M; Stalenhoef AF
    Ann Rheum Dis; 2009 Jun; 68(6):868-72. PubMed ID: 18635596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular risk factors in Chilean patients with rheumatoid arthritis.
    Cisternas M; Gutiérrez MA; Klaassen J; Acosta AM; Jacobelli S
    J Rheumatol; 2002 Aug; 29(8):1619-22. PubMed ID: 12180719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disease activity as a risk factor for myocardial infarction in rheumatoid arthritis.
    Radovits BJ; Popa-Diaconu DA; Popa C; Eijsbouts A; Laan RF; van Riel PL; Fransen J
    Ann Rheum Dis; 2009 Aug; 68(8):1271-6. PubMed ID: 18701555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular risk in rheumatoid arthritis.
    Nurmohamed MT
    Autoimmun Rev; 2009 Jul; 8(8):663-7. PubMed ID: 19393192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Lipid profile and cardiovascular risk in patients with rheumatoid arthritis: Effect of the disease and of drug therapy].
    Hansel B; Bruckert E
    Ann Endocrinol (Paris); 2010 Sep; 71(4):257-63. PubMed ID: 20416859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of synthetic and biological disease modifying antirheumatic drugs on lipid and lipoprotein parameters in patients with rheumatoid arthritis.
    Naerr GW; Rein P; Saely CH; Drexel H
    Vascul Pharmacol; 2016 Jun; 81():22-30. PubMed ID: 26903239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular risk factors in inflammatory arthritis.
    Mirjafari H; Al-Husain A; Bruce IN
    Curr Opin Lipidol; 2011 Aug; 22(4):296-301. PubMed ID: 21670670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of physical inactivity with increased cardiovascular risk in patients with rheumatoid arthritis.
    Metsios GS; Stavropoulos-Kalinoglou A; Panoulas VF; Wilson M; Nevill AM; Koutedakis Y; Kitas GD
    Eur J Cardiovasc Prev Rehabil; 2009 Apr; 16(2):188-94. PubMed ID: 19238083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.